Arcagy/ Gineco Group
Clinical trials sponsored by Arcagy/ Gineco Group, explained in plain language.
-
New drug combo shows promise against advanced cervical cancer
Disease control OngoingThis study tests whether adding relatlimab to nivolumab works better than nivolumab alone for people with locally advanced cervical cancer. About 77 participants will receive one of the two treatments for six weeks before starting standard chemoradiation. The main goal is to see …
Phase: PHASE2 • Sponsor: ARCAGY/ GINECO GROUP • Aim: Disease control
Last updated May 01, 2026 19:27 UTC
-
Immunotherapy shows promise in Tough-to-Treat uterine cancer
Disease control OngoingThis study tests whether the immunotherapy drug dostarlimab works better than standard chemotherapy for women with advanced or recurrent endometrial cancer that has a specific genetic feature (MMR deficient). About 260 participants will be randomly assigned to receive either dost…
Phase: PHASE3 • Sponsor: ARCAGY/ GINECO GROUP • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC